SBFM Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 22:00):

Stats
Dagens volum	31.81M
Gjennomsnittsvolum	1.64M
Markedsverdi	944 803
EPS	$0 ( 2024-04-02 )
Neste inntjeningsdato	( $-8.00 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0500
ATR14	$0.0130 (1.38%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-04	Slilaty Steve N.	Buy	100 000	Series B Preferred Stock
2024-02-08	Slilaty Steve N.	Buy	20 000	Series B Preferred Stock
2024-01-26	Beaudoin Marc	Buy	0
2022-11-30	Sebaaly Camille	Buy	30 000	Common Stock
2022-10-20	Chamoun Malek	Sell	0	Common Stock, par value $0.001 per share

INSIDER POWER
100.00
Last 67 transactions
Buy: 1 074 426 098 \| Sell: 315 420 609

Volum Korrelasjon

Lang: 0.19 (neutral)

Kort: 0.90 (strong)

Signal:(34.554) Same movement expected

Sunshine Biopharma, Inc. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Sunshine Biopharma, Inc. Korrelasjon - Valuta/Råvare

0.79
( moderate )

0.70
( moderate )

0.00
( neutral )

0.72
( moderate )

0.00
( neutral )

0.25
( neutral )

Sunshine Biopharma, Inc. Økonomi

Annual	2023
Omsetning:	$24.09M
Bruttogevinst:	$8.19M (33.99 %)
EPS:	$-0.190

FY	2023
Omsetning:	$24.09M
Bruttogevinst:	$8.19M (33.99 %)
EPS:	$-0.190

FY	2022
Omsetning:	$4.35M
Bruttogevinst:	$1.70M (39.04 %)
EPS:	$-1.760

FY	2021
Omsetning:	$228 426
Bruttogevinst:	$110 596 (48.42 %)
EPS:	$-0.0609

Financial Reports:

No articles found.

Sunshine Biopharma, Inc.

Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name, as well as develops and markets other science-based nutritional supplements. The company has a license agreement with the University of Georgia to advance the development of its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada.